100 related articles for article (PubMed ID: 23543632)
1. Design, synthesis, in vitro cytotoxicity evaluation and structure-activity relationship of goniothalamin analogs.
Mohideen M; Zulkepli S; Nik-Salleh NS; Zulkefeli M; Weber JF; Rahman AF
Arch Pharm Res; 2013 Jul; 36(7):812-31. PubMed ID: 23543632
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of methoxylated goniothalamin, aza-goniothalamin and γ-pyrones and their in vitro evaluation against human cancer cells.
Barcelos RC; Pastre JC; Caixeta V; Vendramini-Costa DB; de Carvalho JE; Pilli RA
Bioorg Med Chem; 2012 Jun; 20(11):3635-51. PubMed ID: 22537680
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and in vitro evaluation against human cancer cells of 5-methyl-5-styryl-2,5-dihydrofuran-2-ones, a new series of goniothalamin analogues.
Bruder M; Vendramini-Costa DB; de Carvalho JE; Pilli RA
Bioorg Med Chem; 2013 Sep; 21(17):5107-17. PubMed ID: 23876338
[TBL] [Abstract][Full Text] [Related]
4. 6-Bicycloaryl substituted (S)- and (R)-5,6-dihydro-2H-pyran-2-ones: asymmetric synthesis, and anti-proliferative properties.
Kasaplar P; Yilmazer O; Cağir A
Bioorg Med Chem; 2009 Jan; 17(1):311-8. PubMed ID: 19022676
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agents.
Han K; Zhou Y; Liu F; Guo Q; Wang P; Yang Y; Song B; Liu W; Yao Q; Teng Y; Yu P
Bioorg Med Chem Lett; 2014 Jan; 24(2):591-4. PubMed ID: 24360564
[TBL] [Abstract][Full Text] [Related]
6. Goniothalamin-Related Styryl Lactones: Isolation, Synthesis, Biological Activity and Mode of Action.
Pilli RA; de Toledo I; Meirelles MA; Grigolo TA
Curr Med Chem; 2019; 26(41):7372-7451. PubMed ID: 30306856
[TBL] [Abstract][Full Text] [Related]
7. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
[TBL] [Abstract][Full Text] [Related]
8. 4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease.
Tait BD; Hagen S; Domagala J; Ellsworth EL; Gajda C; Hamilton HW; Prasad JV; Ferguson D; Graham N; Hupe D; Nouhan C; Tummino PJ; Humblet C; Lunney EA; Pavlovsky A; Rubin J; Gracheck SJ; Baldwin ET; Bhat TN; Erickson JW; Gulnik SV; Liu B
J Med Chem; 1997 Nov; 40(23):3781-92. PubMed ID: 9371244
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Nitrogen-Containing Goniothalamin Analogues with Higher Cytotoxic Activity and Selectivity against Cancer Cells.
Meirelles MA; Braga CB; Ornelas C; Pilli RA
ChemMedChem; 2019 Aug; 14(15):1403-1417. PubMed ID: 31260170
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of the molluscicidal activity of the 5,6-dimethyl-dihydro-pyran-2,4-dione and 6-substituted analogous.
de Souza LC; dos Santos AF; Sant'Ana AE; de Oliveira Imbroisi D
Bioorg Med Chem; 2004 Mar; 12(5):865-9. PubMed ID: 14980598
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic activities of goniothalamins and derivatives.
Weber A; Döhl K; Sachs J; Nordschild ACM; Schröder D; Kulik A; Fischer T; Schmitt L; Teusch N; Pietruszka J
Bioorg Med Chem; 2017 Nov; 25(22):6115-6125. PubMed ID: 28214230
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors.
Rao PN; Uddin MJ; Knaus EE
J Med Chem; 2004 Jul; 47(16):3972-90. PubMed ID: 15267236
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic activity of fluorinated analogues of Goniothalamus lactones. Impact of fluorine on oxidative processes.
Dumitrescu L; Mai Huong DT; Van Hung N; Crousse B; Bonnet-Delpon D
Eur J Med Chem; 2010 Jul; 45(7):3213-8. PubMed ID: 20392543
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective synthesis and biological evaluation of (R)-rugulactone, (6R)-((4R)-hydroxy-6-phenyl-hex-2-enyl)-5,6-dihydro-pyran-2-one and its 4S epimer.
Reddy DK; Shekhar V; Prabhakar P; Chinna Babu B; Siddhardha B; Murthy US; Venkateswarlu Y
Eur J Med Chem; 2010 Oct; 45(10):4657-63. PubMed ID: 20705370
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and cytotoxicity of novel hexacyclic saframycin-ecteinascidin analogs.
Lu X; Pan X; Guan B; Liu Z
Org Biomol Chem; 2020 Jan; 18(2):237-249. PubMed ID: 31782476
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors.
Thaisrivongs S; Romero DL; Tommasi RA; Janakiraman MN; Strohbach JW; Turner SR; Biles C; Morge RR; Johnson PD; Aristoff PA; Tomich PK; Lynn JC; Horng MM; Chong KT; Hinshaw RR; Howe WJ; Finzel BC; Watenpaugh KD
J Med Chem; 1996 Nov; 39(23):4630-42. PubMed ID: 8917652
[TBL] [Abstract][Full Text] [Related]
18. Syntheses and biological activities of dihydro-5,6-dehydrokawain derivatives.
Tawata S; Taira S; Kobamoto N; Ishihara M; Toyama S
Biosci Biotechnol Biochem; 1996 Oct; 60(10):1643-5. PubMed ID: 8987662
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study of arylsulfonylimidazolidinones as anticancer agents.
Sharma VK; Lee KC; Venkateswararao E; Joo C; Kim MS; Sharma N; Jung SH
Bioorg Med Chem Lett; 2011 Nov; 21(22):6829-32. PubMed ID: 21983438
[TBL] [Abstract][Full Text] [Related]
20. (R)-Goniothalamin: total syntheses and cytotoxic activity against cancer cell lines.
de Fátima A; Kohn LK; Antônio MA; de Carvalho JE; Pilli RA
Bioorg Med Chem; 2005 Apr; 13(8):2927-33. PubMed ID: 15781402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
